Kyowa Hakko Kirin Co. Ltd.

Feb 07, 2019

Ardelyx Collaboration Partner, Kyowa Hakko Kirin, Announces Initiation of a Phase 2 Clinical Study of Tenapanor for Hyperphosphatemia Patients on Dialysis in Japan

Dec 03, 2018

Kyowa Kirin Presents Additional Analyses of MAVORIC Trial

Nov 05, 2018

MEI Pharma and Kyowa Hakko Kirin Announce License Agreement to Develop and Commercialize ME-401 in Japan

Sep 20, 2018

Mylan and Fujifilm Kyowa Kirin Biologics Receive European Marketing Authorization for Hulio®, Biosimilar Adalimumab

Jul 27, 2018

Mylan and Fujifilm Kyowa Kirin Biologics Announce Positive CHMP Opinion for Hulio(TM), Biosimilar Adalimumab

Jun 04, 2018

Kyowa Kirin Presents New Data for Mogamulizumab from Its Lead Program in Cutaneous T-cell Lymphoma (CTCL) at ASCO

Mar 07, 2018

Aevi Genomic Medicine Expands Collaboration with Kyowa Hakko Kirin

Dec 11, 2017

Kyowa Hakko Kirin Announces Results of Phase 3 Clinical Study of Mogamulizumab (KW-0761) in Patients with Cutaneous T-cell Lymphoma at the American Society of Hematology 2017

Nov 28, 2017

Ardelyx and Kyowa Hakko Kirin Announce License Agreement for Tenapanor for Cardiorenal Diseases in Japan